Lipoprotein(a) and cardiovascular disease in diabetic patients
about
Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten targetVildagliptin reduces plasma stromal cell-derived factor-1α in patients with type 2 diabetes compared with glimepiride.Body mass index and glycemic control influence lipoproteins in children with type 1 diabetesOverweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetesThe mixed benefit of low lipoprotein(a) in type 2 diabetes.
P2860
Lipoprotein(a) and cardiovascular disease in diabetic patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Lipoprotein(a) and cardiovascular disease in diabetic patients
@ast
Lipoprotein(a) and cardiovascular disease in diabetic patients
@en
type
label
Lipoprotein(a) and cardiovascular disease in diabetic patients
@ast
Lipoprotein(a) and cardiovascular disease in diabetic patients
@en
prefLabel
Lipoprotein(a) and cardiovascular disease in diabetic patients
@ast
Lipoprotein(a) and cardiovascular disease in diabetic patients
@en
P2860
P356
P1433
P1476
Lipoprotein(a) and cardiovascular disease in diabetic patients
@en
P2093
P2860
P304
P356
10.2217/CLP.12.46
P50
P577
2012-08-01T00:00:00Z